SCHEMBL7243793

SCHEMBL7243793

Cc1cc2nc(C)c(N3CCNCC3)nc2cc1C

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 4/20 0.51
CYP1A2 P05177 2/20 0.49
TAAR1 Q96RJ0 1/20 0.48
ADRB1 P08588 2/20 0.46
HTR3E A5X5Y0 1/20 0.45
HTR3B O95264 1/20 0.45
HTR3A P46098 1/20 0.45
HTR3D Q70Z44 1/20 0.45
HTR3C Q8WXA8 1/20 0.45
NCF1 P14598 1/20 0.44
TSHR P16473 2/20 0.44
SOS1 Q07889 4/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243017 0.87 HRH4 (0.69) HRH4CYP1A2TAAR1ADRB1
SCHEMBL30223035 0.83 HRH4 (0.46) HRH4TAAR1ADRB1HTR3EHTR3B
SCHEMBL31652347 0.83 CYP1A2 (0.72) HRH4CYP1A2ADRB1HTR3EHTR3B
SCHEMBL4472647 0.83 CYP1A2 (0.72) HRH4CYP1A2ADRB1HTR3EHTR3B
Hydrochloric Acid SCHEMBL30222975 0.82 HRH4 (0.45) HRH4TAAR1ADRB1HTR3EHTR3B
SCHEMBL10219396 0.78 HTR2C (0.57) HRH4CYP1A2ADRB1HTR3EHTR3B
SCHEMBL2366023 0.77 HRH4 (0.46) HRH4CYP1A2TAAR1ADRB1HTR3E
Hydrochloric Acid SCHEMBL2366308 0.75 HRH4 (0.45) HRH4CYP1A2TAAR1ADRB1NCF1
SCHEMBL6770354 0.73 ADRB1 (0.56) CYP1A2ADRB1HTR3EHTR3BHTR3A
Hydrochloric Acid SCHEMBL30222843 0.72 ADRB1 (0.55) CYP1A2ADRB1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999042463-A1 SUBSTITUTED QUINOXALINE DERIVATIVES AS INTERLEUKIN-8 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-08-26 WO claimed
WO-1999042461-A1 SUBSTITUTED QUINOXALINE DERIVATIVES AS INTERLEUKIN-8 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-08-26 WO claimed
US-6548499-B1 N-(1-Azabicyclo(2.2.2)octanyl-3-pyridinyl)-3-(2-pyridinyl)-2 -quinoxalinamine, for example; treating various chemokine mediated diseases MILLENNIUM PHARMACEUTICALS, INC. 2003-04-15 US disclosed
WO-1999042463-A1 SUBSTITUTED QUINOXALINE DERIVATIVES AS INTERLEUKIN-8 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-08-26 WO disclosed
WO-1999042461-A1 SUBSTITUTED QUINOXALINE DERIVATIVES AS INTERLEUKIN-8 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-08-26 WO disclosed